Last week, the FDA announced a transformative shift in drug development policy that monoclonal antibody (mAb) therapeutics may no longer require testing in animal models. Instead, the agency is endorsing next-generation approaches such as AI modelling and lab-grown human organoids designed to more ...
KRAS is a proto-oncogene that is crucial in regulating cell growth ...
In this edition of Ask the Expert, featuring Dr. Yasmine Abouleila, ...
This "Ask the Experts" feature delves into the pressing inquiries ...
Inflammatory Bowel Disease (IBD) is a complex condition that affects ...
Discover the 6 hallmarks of stemness in adult tissue Mammalian organ ...
In this post of our "Ask the Experts" series, we provide ...
Discover how patient-derived organoids can revolutionize oncology ...
Explore what the new legislative bill means for the future of ...
Learn how to select the right model for your immunotherapy ...